The Herpes Simplex Virus Treatment Market is expected to reach US$ 5.21 billion by 2033, increasing from US$ 2.62 billion in 2024, growing at a CAGR of 7.94% between 2025 and 2033. The market growth is driven by rising global herpes prevalence, increased healthcare spending, improving awareness about sexually transmitted infections, and easier access to antiviral therapies through both offline and online pharmacies. Advancements in antiviral research, introduction of novel formulations, vaccine development initiatives, and enhanced diagnostic accessibility are further reshaping the global HSV treatment landscape.
Global Herpes Simplex Virus Treatment Market OverviewThe global HSV treatment market is rapidly evolving as healthcare systems focus on better antiviral management, awareness, and preventive strategies. Herpes Simple…